文献速递流行病学与生物统计新药、器械与细胞基因治疗研发

双相障碍综述:诊断、机制与治疗

Bipolar disorders.
PubMed 文献 · Lancet · 2020-01-01

双相障碍包括双相I型(躁狂发作)和双相II型(轻躁狂发作和重性抑郁发作),显著降低心理社会功能,预期寿命减少约10-20年,主要死因为心血管疾病和自杀。遗传率约70%,与精神分裂症和重性抑郁障碍共享遗传风险等位基因。锂盐是金标准心境稳定剂,具有抗躁狂、抗抑郁和抗自杀效应;抗精神病药对躁狂有效,但对双相抑郁疗效证据有限。

要点

  • 双相障碍预期寿命减少约10-20年,主要死因为心血管疾病和自杀。
  • 锂盐是金标准心境稳定剂,具有抗躁狂、抗抑郁和抗自杀效应。
  • 抗抑郁药短期或长期疗效证据不足,且可能导致心境不稳定。

核心结论

  • 双相障碍是复杂严重的慢性精神疾病,以抑郁发作和症状为纵向病程主导,锂盐为金标准心境稳定剂。

研究设计与样本

  • 本文为综述,旨在为基层医生概述双相障碍的诊断、病理机制和治疗考虑,综合流行病学、机制、筛查和治疗证据。

主要发现

  • 双相障碍遗传率约70%,与精神分裂症和重性抑郁障碍共享遗传风险等位基因。
  • 双相I型与精神分裂症遗传关联更近,双相II型与重性抑郁障碍遗传关联更近。
  • 双相障碍患者童年期虐待发生率高,且与更复杂的临床表现(如自杀倾向)相关。
  • 抗精神病药对躁狂有效,但少有对双相抑郁有效的药物;丙戊酸盐和卡马西平对急性躁狂有效,拉莫三嗪对双相抑郁有效。
  • 抗抑郁药广泛用于双相障碍,但短期或长期疗效证据不足,且与心境不稳定相关,尤其在维持治疗期间。

临床怎么用

  • 靶向医学和精神共病、整合辅助心理社会治疗、纳入照护者可改善双相障碍患者健康结局。
  • 有效药物治疗在低收入和中等收入国家尤其未普遍可及。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bipolar disorders are a complex group of severe and chronic disorders that includes bipolar I disorder, defined by the presence of a syndromal, manic episode, and bipolar II disorder, defined by the presence of a syndromal, hypomanic episode and a major depressive episode. Bipolar disorders substantially reduce psychosocial functioning and are associated with a loss of approximately 10-20 potential years of life. The mortality gap between populations with bipolar disorders and the general population is principally a result of excess deaths from cardiovascular disease and suicide. Bipolar disorder has a high heritability (approximately 70%). Bipolar disorders share genetic risk alleles with other mental and medical disorders. Bipolar I has a closer genetic association with schizophrenia relative to bipolar II, which has a closer genetic association with major depressive disorder. Although the pathogenesis of bipolar disorders is unknown, implicated processes include disturbances in neuronal-glial plasticity, monoaminergic signalling, inflammatory homoeostasis, cellular metabolic pathways, and mitochondrial function. The high prevalence of childhood maltreatment in people with bipolar disorders and the association between childhood maltreatment and a more complex presentation of bipolar disorder (eg, one including suicidality) highlight the role of adverse environmental exposures on the presentation of bipolar disorders. Although mania defines bipolar I disorder, depressive episodes and symptoms dominate the longitudinal course of, and disproportionately account for morbidity and mortality in, bipolar disorders. Lithium is the gold standard mood-stabilising agent for the treatment of people with bipolar disorders, and has antimanic, antidepressant, and anti-suicide effects. Although antipsychotics are effective in treating mania, few antipsychotics have proven to be effective in bipolar depression. Divalproex and carbamazepine are effective in the treatment of acute mania and lamotrigine is effective at treating and preventing bipolar depression. Antidepressants are widely prescribed for bipolar disorders despite a paucity of compelling evidence for their short-term or long-term efficacy. Moreover, antidepressant prescription in bipolar disorder is associated, in many cases, with mood destabilisation, especially during maintenance treatment. Unfortunately, effective pharmacological treatments for bipolar disorders are not universally available, particularly in low-income and middle-income countries. Targeting medical and psychiatric comorbidity, integrating adjunctive psychosocial treatments, and involving caregivers have been shown to improve health outcomes for people with bipolar disorders. The aim of this Seminar, which is intended mainly for primary care physicians, is to provide an overview of diagnostic, pathogenetic, and treatment considerations in bipolar disorders. Towards the foregoing aim, we review and synthesise evidence on the epidemiology, mechanisms, screening, and treatment of bipolar disorders.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. McIntyre RS, Berk M, Brietzke E, et al. Bipolar disorders. Lancet. 2020. PMID: 33278937. doi:10.1016/S0140-6736(20)31544-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。